NCT02013297
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Months to 20 Years (Child, Adult)
Location of Metastases: Brain, Lung
Additional Notes: 
Exclusions: Patients over 20 years of age
https://ClinicalTrials.gov/show/NCT02013297